Citigroup’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,537
| Closed | -$65.1K | – | 4960 |
|
2024
Q1 | $65.1K | Buy |
1,537
+351
| +30% | +$14.9K | ﹤0.01% | 3758 |
|
2023
Q4 | $49.6K | Buy |
1,186
+1,171
| +7,807% | +$48.9K | ﹤0.01% | 3779 |
|
2023
Q3 | $566 | Sell |
15
-2,489
| -99% | -$93.9K | ﹤0.01% | 4423 |
|
2023
Q2 | $95K | Buy |
2,504
+2,441
| +3,875% | +$92.6K | ﹤0.01% | 3607 |
|
2023
Q1 | $1.53K | Hold |
63
| – | – | ﹤0.01% | 4397 |
|
2022
Q4 | $1.83K | Hold |
63
| – | – | ﹤0.01% | 4494 |
|
2022
Q3 | $2K | Hold |
63
| – | – | ﹤0.01% | 4746 |
|
2022
Q2 | $2K | Hold |
63
| – | – | ﹤0.01% | 5137 |
|
2022
Q1 | $3K | Buy |
+63
| New | +$3K | ﹤0.01% | 5181 |
|
2021
Q4 | – | Sell |
-4,473
| Closed | -$285K | – | 5276 |
|
2021
Q3 | $285K | Buy |
4,473
+3,900
| +681% | +$248K | ﹤0.01% | 3208 |
|
2021
Q2 | $41K | Sell |
573
-21,341
| -97% | -$1.53M | ﹤0.01% | 4247 |
|
2021
Q1 | $1.62M | Buy |
21,914
+614
| +3% | +$45.3K | ﹤0.01% | 2059 |
|
2020
Q4 | $1.56M | Sell |
21,300
-9,800
| -32% | -$720K | ﹤0.01% | 1853 |
|
2020
Q3 | $1.71M | Sell |
31,100
-200
| -0.6% | -$11K | ﹤0.01% | 1600 |
|
2020
Q2 | $2.08M | Hold |
31,300
| – | – | ﹤0.01% | 1598 |
|
2020
Q1 | $1.92M | Buy |
+31,300
| New | +$1.92M | ﹤0.01% | 1411 |
|
2019
Q4 | – | Sell |
-394
| Closed | -$30K | – | 5220 |
|
2019
Q3 | $30K | Buy |
+394
| New | +$30K | ﹤0.01% | 4048 |
|
2018
Q3 | – | Sell |
-29
| Closed | -$3K | – | 5157 |
|
2018
Q2 | $3K | Buy |
29
+20
| +222% | +$2.07K | ﹤0.01% | 4830 |
|
2018
Q1 | $1K | Sell |
9
-530
| -98% | -$58.9K | ﹤0.01% | 4860 |
|
2017
Q4 | $56K | Sell |
539
-4,052
| -88% | -$421K | ﹤0.01% | 3747 |
|
2017
Q3 | $517K | Sell |
4,591
-3,541
| -44% | -$399K | ﹤0.01% | 2402 |
|
2017
Q2 | $911K | Sell |
8,132
-968
| -11% | -$108K | ﹤0.01% | 2042 |
|
2017
Q1 | $1.06M | Buy |
9,100
+1,440
| +19% | +$168K | ﹤0.01% | 1875 |
|
2016
Q4 | $807K | Buy |
7,660
+4,010
| +110% | +$422K | ﹤0.01% | 2546 |
|
2016
Q3 | $403K | Buy |
3,650
+2,234
| +158% | +$247K | ﹤0.01% | 2579 |
|
2016
Q2 | $206K | Sell |
1,416
-1,141
| -45% | -$166K | ﹤0.01% | 2847 |
|
2016
Q1 | $366K | Sell |
2,557
-388
| -13% | -$55.5K | ﹤0.01% | 2969 |
|
2015
Q4 | $455K | Sell |
2,945
-1,629
| -36% | -$252K | ﹤0.01% | 2423 |
|
2015
Q3 | $653K | Buy |
4,574
+2,083
| +84% | +$297K | ﹤0.01% | 2016 |
|
2015
Q2 | $358K | Buy |
2,491
+2,476
| +16,507% | +$356K | ﹤0.01% | 2379 |
|
2015
Q1 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 5252 |
|
2014
Q2 | – | Sell |
-227
| Closed | -$25K | – | 5665 |
|
2014
Q1 | $25K | Buy |
+227
| New | +$25K | ﹤0.01% | 4378 |
|